Cabot (NYSE:CBT – Get Free Report) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 6.000-7.00 for the period, compared to the consensus estimate of 7.610. The company issued revenue guidance of -.
Cabot Trading Down 2.4%
Cabot stock traded down $1.61 during midday trading on Monday, reaching $65.87. The stock had a trading volume of 1,018,515 shares, compared to its average volume of 416,269. Cabot has a twelve month low of $65.40 and a twelve month high of $117.46. The stock has a market capitalization of $3.50 billion, a PE ratio of 8.61 and a beta of 0.88. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. The stock’s 50-day simple moving average is $75.45 and its 200 day simple moving average is $76.09.
Cabot (NYSE:CBT – Get Free Report) last issued its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The firm had revenue of $923.00 million for the quarter, compared to analysts’ expectations of $957.29 million. Analysts expect that Cabot will post 7.57 EPS for the current year.
Analysts Set New Price Targets
Read Our Latest Research Report on CBT
Insider Activity
In other news, CEO Sean D. Keohane sold 114,436 shares of Cabot stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares of the company’s stock, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 3.03% of the company’s stock.
Hedge Funds Weigh In On Cabot
Hedge funds have recently bought and sold shares of the company. Sivia Capital Partners LLC acquired a new position in Cabot in the second quarter worth about $279,000. Brevan Howard Capital Management LP grew its stake in Cabot by 22.3% in the second quarter. Brevan Howard Capital Management LP now owns 14,580 shares of the specialty chemicals company’s stock worth $1,094,000 after purchasing an additional 2,659 shares in the last quarter. Corient Private Wealth LLC grew its stake in Cabot by 4.5% in the second quarter. Corient Private Wealth LLC now owns 14,496 shares of the specialty chemicals company’s stock worth $1,087,000 after purchasing an additional 625 shares in the last quarter. Gabelli Funds LLC acquired a new position in Cabot in the second quarter worth about $1,004,000. Finally, Quantinno Capital Management LP boosted its stake in Cabot by 88.1% in the second quarter. Quantinno Capital Management LP now owns 9,614 shares of the specialty chemicals company’s stock valued at $721,000 after acquiring an additional 4,504 shares during the period. 93.18% of the stock is currently owned by institutional investors and hedge funds.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
See Also
- Five stocks we like better than Cabot
- High Flyers: 3 Natural Gas Stocks for March 2022
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
- Stock Sentiment Analysis: How it Works
- 3 Stocks Flashing Buy Signals With $8.5 Billion in Buybacks
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
